what type of drug is tirzepatide equally effective for early-onset or later-onset 2 diabetes Tirzepatide Oral Tablets – Doctor – Weighing benefits, risks of GLP-1

Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward to minimize gastrointestinal side effects

For moderate overdoses (two to three times the intended dose), symptoms are usually self-limiting

Its ideal for those wanting moderate weight loss (around 59% of body weight), especially if they struggle with cravings or mood-related eating

This means that the caloric deficit created by Mounjaros appetite suppression gradually narrows as weight is lost

Some people who took Mounjaro have developed NAION and have filed lawsuits against Eli Lilly, accusing the company of not warning about the possible connection